Drug-eruptions are common adverse events that may be potentially severe. This review focuses on the principal clinical presentations of drug-eruptions, the identification procedure of the causal drug and the best ways of notifying serious or unexpected adverse events (pharmaco-vigilance) in order to identify the high-risk therapeutic classes.